Key facts
- Lōvu’s last known valuation is $31.0M (May 2025).
- It has raised $14.9M; the latest was Early Stage VC ($8.0M) in May 2025.
- Notable investors include Alumni Ventures, Matter (Consulting Services (B2B)), Sand Hill Angels, SJF Ventures, Swizzle Ventures — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Lōvu
- ·The full record, as it builds
Funding rounds
No funding rounds for Lōvu are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lōvu
Developer of an AI-enabled care platform designed to increase awareness by delivering instant analytics and evidence-based insights. The company's platform offers features like observing fetal heart rate and blood pressure, evidence-based recommendations, action-oriented alerts, self-monitoring insights and identifying potentially life-threatening conditions, enabling patients with rapid access, reliable information and evidence-based know-how.
- Sector
- Healthcare
- HQ
- Los Gatos, CA, United States
- Founded
- 2022
- Employees
- 25
- Website
- lovu.health/
- Ownership
- Privately Held (backing)
Lōvu doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lōvu shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lōvu in its N-PORT filings yet. We sweep new filings monthly.